Search Results - "Harnois, D. M."

The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular‐Cholangiocarcinoma by Panjala, C., Senecal, D. L., Bridges, M. D., Kim, G. P., Nakhleh, R. E., Nguyen, J. H. H., Harnois, D. M.

“…Combined hepatocellular‐cholangiocarcinoma (cHCC‐CC) is a rare primary liver malignancy with mixed hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC)…”
Get full text

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis by Patel, Anand H, Harnois, Denise M, Klee, George G, LaRusso, Nicholas F, Gores, Gregory J

“…The diagnosis of cholangiocarcinoma is often difficult, making management approaches problematic. A reliable serum tumor marker for cholangiocarcinoma would be…”
Get full text

Bcl‐2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line by Harnois, D M, Que, F G, Celli, A, LaRusso, N F, Gores, G J

“…Cholangiocarcinoma is a malignant neoplasm originating from cholangiocytes. The mechanisms responsible for oncogenesis of cholangiocytes are unknown…”
Get full text

The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma by Croome, K. P., Lee, D. D., Burns, J. M., Musto, K., Paz, D., Nguyen, J. H., Perry, D. K., Harnois, D. M., Taner, C. B.

“…Hepatocellular carcinoma (HCC) recurrence in patients undergoing liver transplantation (LT) with donation after brain death (DBD) and donation after cardiac…”
Get full text

Allograft Portacaval Shunt in Small-for-Size Liver in Deceased Donor Liver Transplant by Nguyen, J.H., Harnois, D.M.

“…Portal hyperperfusion is detrimental to small-for-size livers (SFSLs) in liver transplantation. Surgical techniques modulating portal inflow provide the most…”
Get full text

Incidence and Outcome of Small-for-Size Liver Grafts Transplanted in Adult Recipients by Nguyen, J.H., Harnois, D.M.

“…Small-for-size liver transplantation (SFS-LT) carries high morbidity and mortality after transplantation. SFS-LT is usually associated with living-donor or…”
Get full text

Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? by Harnois, Denise M., Gores, Gregory J., Ludwig, Jurgen, Steers, Jeffery L., LaRusso, Nicholas F., Wiesner, Russell H.

“…Background/Aims: The risk of cholangiocarcinoma in primary sclerosing cholangitis is widely recognized to be 8–30%, whereas the risk of acquiring…”
Get full text

Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma by Harnois, Denise M., Steers, Jeffery, Andrews, James C., Rubin, Joseph C., Pitot, Henry C., Burgart, Lawrence, Wiesner, Russell H., Gores, Gregory J.

“…In our experience, the primary obstacle precluding the widespread use of orthotopic liver transplantation (OLT) for definitive therapy of hepatocellular…”
Get full text

Abatacept Use in Graft-Versus-Host Disease After Orthotopic Liver Transplantation: A Case Report by Elfeki, M.A, Genco, P.V, Pungpapong, S, Nakhleh, R.E, Nguyen, J.H, Harnois, D.M

“…Abstract Background Graft-versus-host disease (GVHD) is a rare, serious, fatal disease that occurs after orthotopic liver transplantation (OLT). Case Report We…”
Get full text

Choice of Partial Splenic Embolization Technique in Liver Transplant Recipients Correlates With Risk of Infectious Complications by Elfeki, M.A, Paz-Fumagalli, R, Tiemeier, A.M, Pungpapong, S, Sella, D.M, Frey, G.T, Musto, K.R, Nguyen, J.H, Harnois, D.M

“…Abstract Background Complications of cirrhosis may persist after liver transplantation. When indicated, partial splenic embolization (PSE) is an alternative to…”
Get full text

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis by Harnois, Denise M., Angulo, Paul, Jorgensen, Roberta A., LaRusso, Nicholas F., Lindor, Keith D.

“…To assess the tolerability and efficacy of high-dose (25–30 mg/kg per day) ursodeoxycholic acid (UDCA) in patients with primary sclerosing cholangitis (PSC)…”
Get full text

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C by MACHICAO, Victor I, BONATTI, Hugo, HARNOIS, Denise M, CROOK, Julia E, STEERS, Jeffery L, DICKSON, Rolland C, KRISHNA, Murli, AQEL, Bashar A, LUKENS, Frank J, NGUYEN, Justin H, ROSSER, Barry G, SATYANARAYANA, Raj, GREWAL, Hani P, HEWITT, Winston R

“…The use of liver allografts from an older donor (OD) (age>50 years) is a widespread strategy to manage the disparity between supply and demand of organs for…”
Get full text

Levetiracetam monotherapy for liver transplant patients with seizures by Chabolla, D.R., Harnois, D.M., Meschia, J.F.

“…Selecting an appropriate anticonvulsant for treatment of recipients of orthostatic liver transplants who have new-onset epileptic seizures can be challenging…”
Get full text

Primary sclerosing cholangitis: evolving concepts in diagnosis and treatment by Harnois, D M, Lindor, K D

“…Primary sclerosing cholangitis is an increasingly recognized cause of chronic cholestatic liver disease. The etiology is unknown, although a number of…”
Get more information

Sexual dimorphism in the incidence of human cancers by Zheng, Daoshan, Trynda, Justyna, Williams, Cecilia, Vold, Jeremy A, Nguyen, Justin H, Harnois, Denise M, Bagaria, Sanjay P, McLaughlin, Sarah A, Li, Zhaoyu

“…Sex differences in the incidences of cancers become a critical issue in both cancer research and the development of precision medicine. However, details in…”
Get full text

Regulation of sex hormone receptors in sexual dimorphism of human cancers by Zheng, Daoshan, Williams, Cecilia, Vold, Jeremy A., Nguyen, Justin H., Harnois, Denise M., Bagaria, Sanjay P., McLaughlin, Sarah A., Li, Zhaoyu

“…Gender differences in the incidences of cancers have been found in almost all human cancers. However, the mechanisms that underlie gender disparities in most…”
Get full text

Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis by De la Garza-Ramos, Cynthia, Montazeri, S Ali, Musto, Kaitlyn R, Kapp, Melissa D, Lewis, Andrew R, Frey, Gregory, Paz-Fumagalli, Ricardo, Ilyas, Sumera, Harnois, Denise M, Majeed, Umair, Patel, Tushar, Toskich, Beau

“…To compare the outcomes of radiation segmentectomy for early-stage hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD)…”
Get full text

DOES IMMUNOSUPPRESSION (IS) CHANGE THE NATURAL HISTORY OF IPMNS? by Gill, K. R. S., Gross, S. A., Al-Haddad, M., Harnois, D. M., Keaveny, A. P., Woodward, T. A., Wallace, M. B., Raimondo, M.

Get full text

DCD Liver Grafts Can Safely Be Used for Recipients With Grade I–II Portal Vein Thrombosis: A Multicenter Analysis by Mercado, Lydia A., Bhangu, Harpreet K., Calderon, Esteban, Mathur, Amit K., Aqel, Bashar, Musto, Kaitlyn R., Watt, Kymberly D., Rosen, Charles B., Bolan, Candice, LeGout, Jordan D., Taner, C. Burcin, Harnois, Denise M., Croome, Kristopher P.

“…Background. With donation after circulatory death (DCD) liver transplantation (LT), the goal of the recipient implantation procedure is to minimize surgical…”
Get full text

Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting by De la Garza-Ramos, Cynthia, Muneer, Mohamed S., Lewis, Jason T., Harnois, Denise M., Taner, C. Burcin, Frey, Gregory T., Rosser, Barry, Toskich, Beau B.

“…Nodular regenerative hyperplasia (NRH) of the liver may lead to noncirrhotic portal hypertension with subsequent development of portosystemic shunts. While…”
Get full text